Asymptomatic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: Extent and implications for infection control: A systematic review

Abstract

Background: The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) emerged in 2012 and attracted an international attention as the virus caused multiple healthcare associated outbreaks. There are reports of the role of asymptomatic individuals in the transmission of MERS-CoV, however, the exact role is not known. Method: The MEDLINE/PubMed and Scopus databases were searched for relevant papers published till August 2018 describing asymptomatic MERS-CoV infection.Results: A total of 10 papers were retrieved and included in the final analysis and review. The extent of asymptomatic MERS infection had increased with change in the policy of testing asymptomatic contacts. In early cases in April 2012-October 2013, 12.5% were asymptomatic among 144 PCR laboratory-confirmed MERS-CoV cases while in 2014 the proportion rose to 25.1% among 255 confirmed cases. The proportion of asymptomatic cases reported among pediatric confirmed MERS-CoV cases were higher (41.9%-81.8%). Overall, the detection rate of MERS infection among asymptomatic contacts was 1-3.9% in studies included in this review. Asymptomatic individuals were less likely to have underlying condition compared to fatal cases. Of particular interest is that most of the identified pediatric cases were asymptomatic with no clear explanation.Conclusions: The proportion of asymptomatic MERS cases were detected with increasing frequency as the disease progressed overtime. Those patients were less likely to have comorbid disease and may contribute to the transmission of the virus. * Corresponding author.

New and emerging infectious diseases (Ebola, Middle Eastern respiratory syndrome coronavirus, carbapenem-resistant Enterobacteriaceae, Candida auris): Focus on environmental survival and germicide susceptibility

“…Importantly, MERS may be transmitted from an asymptomatic source. 73 However, super spreaders have also been reported. 74 The epidemiology and prevention of MERS in health care settings has been reviewed.…”

Clinical predictors of mortality of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: A cohort study

“…A single case of travel associated MERS-CoV infections caused the largest outbreak outside the Arabian Peninsula in South Korea [13,[15][16][17] pilgrims showed no infections [18]. There had been no asymptomatic MERS-CoV cases among travelers despite a high proportion in nontravelers [19]. A recent study included confirmed cases who were admitted to this hospital in 2014-2015 and found independent predictors of survival as younger age, not being transferred to the ICU and not receiving renal replacement therapy [20].…”

The next big threat to global health? 2019 novel coronavirus (2019-nCoV): What advice can we give to travellers? – Interim recommendations January 2020, from the Latin-American society for Travel Medicine (SLAMVI)

“…The emergence of coronaviruses infections with high impact in public health began in 2002-2003 with the SARS outbreak [12,13] and in 2012, MERS-CoV, another highly-pathogenic coronavirus which still circulates in the Middle East and causes severe respiratory disease [14,15] was reported.…”